Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group (Q34629100)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group |
scientific article |
Statements
1 reference
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group (English)
1 reference
Uwe Pelzer
1 reference
Ingo Schwaner
1 reference
Jens Stieler
1 reference
Mathias Adler
1 reference
Jörg Seraphin
1 reference
Bernd Dörken
1 reference
Hanno Riess
1 reference
Helmut Oettle
1 reference
1 reference
Identifiers
1 reference